|
Name |
Epicoccolide B
|
| Molecular Formula | C18H14O8 | |
| IUPAC Name* |
2-(2-formyl-3,4,5-trihydroxy-6-methylphenyl)-6,7-dihydroxy-5-methyl-1-benzofuran-4-carbaldehyde
|
|
| SMILES |
CC1=C(C2=C(C(=C1O)O)OC(=C2)C3=C(C(=C(C(=C3C=O)O)O)O)C)C=O
|
|
| InChI |
InChI=1S/C18H14O8/c1-6-9(4-19)8-3-11(26-18(8)17(25)13(6)21)12-7(2)14(22)16(24)15(23)10(12)5-20/h3-5,21-25H,1-2H3
|
|
| InChIKey |
HTCVSLIHSFBUEL-UHFFFAOYSA-N
|
|
| Synonyms |
Epicoccolide B; CHEMBL3104855; Epicoccolide B_130095; SCHEMBL14563907; BDBM50445474; 2-(2-formyl-3,4,5-trihydroxy-6-methyl-phenyl)-6,7-dihydroxy-5-methyl-benzofuran-4-carbaldehyde
|
|
| CAS | NA | |
| PubChem CID | 11210533 | |
| ChEMBL ID | CHEMBL3104855 |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 358.3 | ALogp: | 2.4 |
| HBD: | 5 | HBA: | 8 |
| Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 148.0 | Aromatic Rings: | 3 |
| Heavy Atoms: | 26 | QED Weighted: | 0.352 |
| Caco-2 Permeability: | -5.586 | MDCK Permeability: | 0.00000595 |
| Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.007 |
| Human Intestinal Absorption (HIA): | 0.262 | 20% Bioavailability (F20%): | 0.952 |
| 30% Bioavailability (F30%): | 0.996 |
| Blood-Brain-Barrier Penetration (BBB): | 0.001 | Plasma Protein Binding (PPB): | 97.08% |
| Volume Distribution (VD): | 0.627 | Fu: | 5.94% |
| CYP1A2-inhibitor: | 0.558 | CYP1A2-substrate: | 0.137 |
| CYP2C19-inhibitor: | 0.014 | CYP2C19-substrate: | 0.056 |
| CYP2C9-inhibitor: | 0.349 | CYP2C9-substrate: | 0.121 |
| CYP2D6-inhibitor: | 0.009 | CYP2D6-substrate: | 0.141 |
| CYP3A4-inhibitor: | 0.09 | CYP3A4-substrate: | 0.048 |
| Clearance (CL): | 5.235 | Half-life (T1/2): | 0.891 |
| hERG Blockers: | 0.001 | Human Hepatotoxicity (H-HT): | 0.039 |
| Drug-inuced Liver Injury (DILI): | 0.948 | AMES Toxicity: | 0.272 |
| Rat Oral Acute Toxicity: | 0.006 | Maximum Recommended Daily Dose: | 0.919 |
| Skin Sensitization: | 0.822 | Carcinogencity: | 0.037 |
| Eye Corrosion: | 0.007 | Eye Irritation: | 0.919 |
| Respiratory Toxicity: | 0.219 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002948 | ![]() |
0.516 | D0K8KX | ![]() |
0.252 | ||
| ENC002997 | ![]() |
0.500 | D04AIT | ![]() |
0.221 | ||
| ENC001496 | ![]() |
0.479 | D0WY9N | ![]() |
0.217 | ||
| ENC003996 | ![]() |
0.377 | D0FA2O | ![]() |
0.208 | ||
| ENC003994 | ![]() |
0.377 | D06JGH | ![]() |
0.207 | ||
| ENC003995 | ![]() |
0.377 | D06GCK | ![]() |
0.200 | ||
| ENC004989 | ![]() |
0.370 | D0FX2Q | ![]() |
0.195 | ||
| ENC004923 | ![]() |
0.359 | D07JHH | ![]() |
0.192 | ||
| ENC002859 | ![]() |
0.356 | D08PCE | ![]() |
0.188 | ||
| ENC004842 | ![]() |
0.327 | D0G3DL | ![]() |
0.188 | ||